These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 76422)

  • 21. [Antigenic analysis of the structural components of the surface of BCG cells].
    Shimono T; Kotani S; Kato K; Hirachi Y
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):90. PubMed ID: 765574
    [No Abstract]   [Full Text] [Related]  

  • 22. The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system.
    Closs O; Harboe M; Axelsen NH; Bunch-Christensen K; Magnusson M
    Scand J Immunol; 1980; 12(3):249-63. PubMed ID: 7008186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
    Frenette M; Portelance V; Beaudet R
    Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG.
    Harboe M; Nagai S; Patarroyo ME; Torres ML; Ramirez C; Cruz N
    Infect Immun; 1986 Apr; 52(1):293-302. PubMed ID: 3514457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG).
    Harboe M; Closs O; Deverill J
    Scand J Immunol; 1976; 5(6-7):861-6. PubMed ID: 790542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatic and antigenic analyses of strains of Mycobacterium bovis, M. bovis BCG, and M. tuberculosis.
    Ohman R; Ridell M
    Curr Microbiol; 1995 Mar; 30(3):161-5. PubMed ID: 7765849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of immunologic methods for the detection of dehydrogenases of BCG substrains].
    Lipińska R
    Pneumonol Pol; 1976 Feb; 44(2):113-8. PubMed ID: 821044
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative immunogenicity of BCG substrains for mice.
    Júnior LP; Gontijo Filho PP
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):311-6. PubMed ID: 394227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinic acid production of BCG substrains in relationship to their residual virulence and immunogenic efficacy.
    Zureck A
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):436-43. PubMed ID: 812905
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of two subpopulations of Bacillus Calmette-Guérin (BCG) Tokyo172 substrain with different RD16 regions.
    Honda I; Seki M; Ikeda N; Yamamoto S; Yano I; Koyama A; Toida I
    Vaccine; 2006 Jun; 24(23):4969-74. PubMed ID: 16621197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of subcellular components of BCG for studying host-Mycobacterium interaction in relation to leprosy.
    Das PK; Ibrahim AA; Binkhuysen F; Thi Hué P; Qui TH; Rangarajan R; Ruitenberg EJ
    Ann Immunol (Paris); 1982; 133D(1):41-59. PubMed ID: 6760793
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antigens common to human malignant tumors and certain species of microorganisms].
    Zhukov-Verezhnikov NN; Lomakin MS; Maĭskiĭ IN; Larin AS; Bochko GM
    Biull Eksp Biol Med; 1981 Sep; 92(9):331-3. PubMed ID: 6794672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin].
    Kulagin PP; Martynova VA
    Probl Tuberk; 1967; 45(9):74-7. PubMed ID: 4975371
    [No Abstract]   [Full Text] [Related]  

  • 34. Mycobacterium tuberculosis tuberculin devoid of BCG common antigens.
    Stavri D; Stavri H; Claiciu I; Niculescu D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):399-401. PubMed ID: 6805158
    [No Abstract]   [Full Text] [Related]  

  • 35. Preparation of a BCG substrain specific elicitin.
    Niculescu D; Stavri D
    Arch Roum Pathol Exp Microbiol; 1981; 40(2):117-22. PubMed ID: 7030273
    [No Abstract]   [Full Text] [Related]  

  • 36. The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with a reference system for Mycobacterium bovis, BCG.
    Wiker HG; Harboe M; Bennedsen J; Closs O
    Scand J Immunol; 1988 Feb; 27(2):223-39. PubMed ID: 3124264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the antigen 85 complex fibronectin-binding proteins derived from aged culture filtrates of Mycobacterium bovis BCG, Tice substrain.
    Oner F; Tian XX; Son K; Klegerman ME; Groves MJ
    Microbios; 1994; 78(315):69-81. PubMed ID: 8047024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of substrains of BCG vaccine using multiplex PCR.
    Bedwell J; Kairo SK; Behr MA; Bygraves JA
    Vaccine; 2001 Feb; 19(15-16):2146-51. PubMed ID: 11228387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of two dimensional immunoelectrophoretic method in the study of the antigenic relationships of "Mycobacterium simiae" and "M. habana" (author's transl)].
    Thorel MF
    Ann Microbiol (Paris); 1976 Jul; 127(1):41-55. PubMed ID: 65934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain.
    Lou Y; Klegerman ME; Muhammad A; Dai X; Groves MJ
    Anticancer Res; 1994; 14(4A):1469-75. PubMed ID: 7979173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.